The Hub for Disease-Specific Clinical Information
Advertisement
Advertisement

Matthew A. Gubens, MD, on Non–Small Cell Lung Cancer: Is There Still a Role for Chemotherapy?

Posted: Sunday, April 7, 2019

Matthew A. Gubens, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center, discusses the increasing use of immune checkpoint inhibitors, therapeutic vaccines, and adoptive T-cell therapy for non–small cell lung cancer, and how chemotherapy will fit into the treatment armamentarium.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.